Cargando…
3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice
3,5,3′-triiodo-L-thyronine (T3) and 3,5-diiodo-L-thyronine (T2), when administered to a model of familial hypercholesterolemia, i.e., low density lipoprotein receptor (LDLr)-knockout (Ldlr(−/−)) mice fed with a Western type diet (WTD), dramatically reduce circulating total and very low-density lipop...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112267/ https://www.ncbi.nlm.nih.gov/pubmed/27909409 http://dx.doi.org/10.3389/fphys.2016.00545 |
_version_ | 1782467961161777152 |
---|---|
author | Moreno, Maria Silvestri, Elena Coppola, Maria Goldberg, Ira J. Huang, Li-Shin Salzano, Anna M. D'Angelo, Fulvio Ehrenkranz, Joel R. Goglia, Fernando |
author_facet | Moreno, Maria Silvestri, Elena Coppola, Maria Goldberg, Ira J. Huang, Li-Shin Salzano, Anna M. D'Angelo, Fulvio Ehrenkranz, Joel R. Goglia, Fernando |
author_sort | Moreno, Maria |
collection | PubMed |
description | 3,5,3′-triiodo-L-thyronine (T3) and 3,5-diiodo-L-thyronine (T2), when administered to a model of familial hypercholesterolemia, i.e., low density lipoprotein receptor (LDLr)-knockout (Ldlr(−/−)) mice fed with a Western type diet (WTD), dramatically reduce circulating total and very low-density lipoprotein/LDL cholesterol with decreased liver apolipoprotein B (ApoB) production. The aim of the study was to highlight putative molecular mechanisms to manage cholesterol levels in the absence of LDLr. A comprehensive comparative profiling of changes in expression of soluble proteins in livers from Ldlr(−/−) mice treated with either T3 or T2 was performed. From a total proteome of 450 liver proteins, 25 identified proteins were affected by both T2 and T3, 18 only by T3 and 9 only by T2. Using in silico analyses, an overlap was observed with 11/14 pathways common to both iodothyronines, with T2 and T3 preferentially altering sub-networks centered around hepatocyte nuclear factor 4 α (HNF4α) and peroxisome proliferator-activated receptor α (PPARα), respectively. Both T2 and T3 administration significantly reduced nuclear HNF4α protein content, while T2, but not T3, decreased the expression levels of the HNFα transcriptional coactivator PGC-1α. Lower PPARα levels were found only following T3 treatment while both T3 and T2 lowered liver X receptor α (LXRα) nuclear content. Overall, this study, although it was not meant to investigate the use of T2 and T3 as a therapeutic agent, provides novel insights into the regulation of hepatic metabolic pathways involved in T3- and T2-driven cholesterol reduction in Ldlr(−/−) mice. |
format | Online Article Text |
id | pubmed-5112267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-51122672016-12-01 3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice Moreno, Maria Silvestri, Elena Coppola, Maria Goldberg, Ira J. Huang, Li-Shin Salzano, Anna M. D'Angelo, Fulvio Ehrenkranz, Joel R. Goglia, Fernando Front Physiol Physiology 3,5,3′-triiodo-L-thyronine (T3) and 3,5-diiodo-L-thyronine (T2), when administered to a model of familial hypercholesterolemia, i.e., low density lipoprotein receptor (LDLr)-knockout (Ldlr(−/−)) mice fed with a Western type diet (WTD), dramatically reduce circulating total and very low-density lipoprotein/LDL cholesterol with decreased liver apolipoprotein B (ApoB) production. The aim of the study was to highlight putative molecular mechanisms to manage cholesterol levels in the absence of LDLr. A comprehensive comparative profiling of changes in expression of soluble proteins in livers from Ldlr(−/−) mice treated with either T3 or T2 was performed. From a total proteome of 450 liver proteins, 25 identified proteins were affected by both T2 and T3, 18 only by T3 and 9 only by T2. Using in silico analyses, an overlap was observed with 11/14 pathways common to both iodothyronines, with T2 and T3 preferentially altering sub-networks centered around hepatocyte nuclear factor 4 α (HNF4α) and peroxisome proliferator-activated receptor α (PPARα), respectively. Both T2 and T3 administration significantly reduced nuclear HNF4α protein content, while T2, but not T3, decreased the expression levels of the HNFα transcriptional coactivator PGC-1α. Lower PPARα levels were found only following T3 treatment while both T3 and T2 lowered liver X receptor α (LXRα) nuclear content. Overall, this study, although it was not meant to investigate the use of T2 and T3 as a therapeutic agent, provides novel insights into the regulation of hepatic metabolic pathways involved in T3- and T2-driven cholesterol reduction in Ldlr(−/−) mice. Frontiers Media S.A. 2016-11-17 /pmc/articles/PMC5112267/ /pubmed/27909409 http://dx.doi.org/10.3389/fphys.2016.00545 Text en Copyright © 2016 Moreno, Silvestri, Coppola, Goldberg, Huang, Salzano, D'Angelo, Ehrenkranz and Goglia. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Moreno, Maria Silvestri, Elena Coppola, Maria Goldberg, Ira J. Huang, Li-Shin Salzano, Anna M. D'Angelo, Fulvio Ehrenkranz, Joel R. Goglia, Fernando 3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice |
title | 3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice |
title_full | 3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice |
title_fullStr | 3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice |
title_full_unstemmed | 3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice |
title_short | 3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice |
title_sort | 3,5,3′-triiodo-l-thyronine- and 3,5-diiodo-l-thyronine- affected metabolic pathways in liver of ldl receptor deficient mice |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112267/ https://www.ncbi.nlm.nih.gov/pubmed/27909409 http://dx.doi.org/10.3389/fphys.2016.00545 |
work_keys_str_mv | AT morenomaria 353triiodolthyronineand35diiodolthyronineaffectedmetabolicpathwaysinliverofldlreceptordeficientmice AT silvestrielena 353triiodolthyronineand35diiodolthyronineaffectedmetabolicpathwaysinliverofldlreceptordeficientmice AT coppolamaria 353triiodolthyronineand35diiodolthyronineaffectedmetabolicpathwaysinliverofldlreceptordeficientmice AT goldbergiraj 353triiodolthyronineand35diiodolthyronineaffectedmetabolicpathwaysinliverofldlreceptordeficientmice AT huanglishin 353triiodolthyronineand35diiodolthyronineaffectedmetabolicpathwaysinliverofldlreceptordeficientmice AT salzanoannam 353triiodolthyronineand35diiodolthyronineaffectedmetabolicpathwaysinliverofldlreceptordeficientmice AT dangelofulvio 353triiodolthyronineand35diiodolthyronineaffectedmetabolicpathwaysinliverofldlreceptordeficientmice AT ehrenkranzjoelr 353triiodolthyronineand35diiodolthyronineaffectedmetabolicpathwaysinliverofldlreceptordeficientmice AT gogliafernando 353triiodolthyronineand35diiodolthyronineaffectedmetabolicpathwaysinliverofldlreceptordeficientmice |